Fig. 1From: Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetesProportion of patients (in %) on each single molecule and dosage according to presence or absence of diabetes and recorded cardiovascular events. Area under the blue area (i.e. statin alone) is 100%, sum of pink area (i.e., statin + ezetimibe) is 100%, in each of the four panelBack to article page